OA-4 Thioredoxin-1 and Geranylgeranylacetone Resist Neurotoxicity of Amyloid-β
關鍵詞：disease cognitive function
摘要：Objective:Alzheimer's disease (AD) is the most common neurodegenerative disorder which is characterized by amyloid-β( Aβ) aggradation in the brain and impairment of cognitive function. Thioredoxin-1( Trx-1) is a redox regulating protein,and plays roles in resisting the oxidative stress and protecting neurons. Our previous study found that Trx-1 improved the cognitive function of Parkinson's Disease (PD) mice. Geranylgeranylacetone (GGA) is an antiulcer drug and induces the expression of Trx-1 in vivo and in vitro. However,whether Trx-1 improves cognitive functions in mice of APP/PS1 or GGA protects SH-SY5Y cells from cytotoxicity induced by Aβ is still unknown. The objective of present is to investigate the roles of Trx-1 and GGA in inhibiting neurotoxicity of Aβ. Methods:We used MTT assay to test the cell viability induced by Aβ(25-35) and western blot to detect the expression of Trx-1 in SH-SY5Y cells. Trx-1 overexpression transgenic mice were hybridized with APP/PS1 transgenic mice to get control,Trx-1,Tx-1/APP/PS1 and APP/PS1 mice. Then we used Morris water maze,high plus maze and object recognition test to detect the cognitive function of different kinds of mice. We also used RT-PCR and western blot to test the mRNA level and expression of Trx-1,APP,PS1 and Aβ. Results:In our present study,we demonstrated that Aβ(25-35) decreased the cell viability and the expression of Trx-1 in SH-SY5Y cells. The cell viability and the expression of Trx-1 were reversed by GGA. Our results showed that the escape latency in APP/PS1 mice was longer when compared with the Trx-1/APP/PS1 mice in Morris water maze and high plus maze. Whereas navigational experiments in Morris water maze result showed that the total number of crossings and the percentage of time spent in the target quadrant were significantly decreased in APP/PS1 mice when compared to Trx-1/APP/PS1 mice. Object recognition 1/APP/PS1 mice. The mRNA levels and the expression of APP,PS1 and Aβ were decreased in Trx- 1/APP/PS1 mice when compared to APP/PS1 mice
神經藥理學報雜志要求:
{1}包括真實姓名、性別、出生年、職務職稱、學位、研究方向、聯系電話、E-mail、郵編等。
{2}文稿應論點明確、資料可靠、數據精確、文字精煉、層次清晰。
{3}年份中的前兩位數不可省略，如：‘'01年”應為“2001年”。
{4}注釋：主要用于對文章篇名、作者及文內某一專題內容作必要的解釋或說明。序號在注釋處右上角用阿拉伯數字①②等表示。
{5}正文應盡量減少層次，一般不宜超過3層。有標題內容才列數字序號（沒有標題的內容用自然段形式起始），數字序號后不用加點，但要空1格。
注：因版權方要求，不能公開全文，如需全文，請咨詢雜志社
